| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.005 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.006 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.009 |